130 related articles for article (PubMed ID: 25002122)
1. Niche anchorage and signaling through membrane-bound Kit-ligand/c-kit receptor are kinase independent and imatinib insensitive.
Tabone-Eglinger S; Calderin-Sollet Z; Pinon P; Aebischer N; Wehrle-Haller M; Jacquier MC; Boettiger D; Wehrle-Haller B
FASEB J; 2014 Oct; 28(10):4441-56. PubMed ID: 25002122
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol 3'-kinase is required for growth of mast cells expressing the kit catalytic domain mutant.
Shivakrupa R; Bernstein A; Watring N; Linnekin D
Cancer Res; 2003 Aug; 63(15):4412-9. PubMed ID: 12907613
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis.
Juurikivi A; Sandler C; Lindstedt KA; Kovanen PT; Juutilainen T; Leskinen MJ; Mäki T; Eklund KK
Ann Rheum Dis; 2005 Aug; 64(8):1126-31. PubMed ID: 16014680
[TBL] [Abstract][Full Text] [Related]
4. A role for kit receptor signaling in Leydig cell steroidogenesis.
Rothschild G; Sottas CM; Kissel H; Agosti V; Manova K; Hardy MP; Besmer P
Biol Reprod; 2003 Sep; 69(3):925-32. PubMed ID: 12773427
[TBL] [Abstract][Full Text] [Related]
5. C-Kit controls IL-1β-induced effector functions in HMC-cells.
Drube S; Schmitz F; Göpfert C; Weber F; Kamradt T
Eur J Pharmacol; 2012 Jan; 675(1-3):57-62. PubMed ID: 22173128
[TBL] [Abstract][Full Text] [Related]
6. Fps/Fes protein-tyrosine kinase regulates mast cell adhesion and migration downstream of Kit and beta1 integrin receptors.
Smith JA; Samayawardhena LA; Craig AW
Cell Signal; 2010 Mar; 22(3):427-36. PubMed ID: 19892014
[TBL] [Abstract][Full Text] [Related]
7. c-kit receptor signaling through its phosphatidylinositide-3'-kinase-binding site and protein kinase C: role in mast cell enhancement of degranulation, adhesion, and membrane ruffling.
Vosseller K; Stella G; Yee NS; Besmer P
Mol Biol Cell; 1997 May; 8(5):909-22. PubMed ID: 9168474
[TBL] [Abstract][Full Text] [Related]
8. Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies.
Schittenhelm MM; Shiraga S; Schroeder A; Corbin AS; Griffith D; Lee FY; Bokemeyer C; Deininger MW; Druker BJ; Heinrich MC
Cancer Res; 2006 Jan; 66(1):473-81. PubMed ID: 16397263
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of human cells bearing oncogenic mutant kit isoforms to the novel tyrosine kinase inhibitor INNO-406.
Pan J; Quintás-Cardama A; Manshouri T; Cortes J; Kantarjian H; Verstovsek S
Cancer Sci; 2007 Aug; 98(8):1223-5. PubMed ID: 17517053
[TBL] [Abstract][Full Text] [Related]
10. Imatinib mesylate (Gleevec) induces human corpus cavernosum relaxation by inhibiting receptor tyrosine kinases (RTKs): identification of new RTK targets.
Gur S; Sikka SC; Abdel-Mageed AB; Abd Elmageed ZY; Rezk B; Pankey E; Kadowitz PJ; Hellstrom WJ
Urology; 2013 Sep; 82(3):745.e11-6. PubMed ID: 23856589
[TBL] [Abstract][Full Text] [Related]
11. Novel thiazole amine class tyrosine kinase inhibitors induce apoptosis in human mast cells expressing D816V KIT mutation.
Jin Y; Ding K; Wang D; Shen M; Pan J
Cancer Lett; 2014 Oct; 353(1):115-23. PubMed ID: 25088577
[TBL] [Abstract][Full Text] [Related]
12. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.
Samayawardhena LA; Hu J; Stein PL; Craig AW
Cell Signal; 2006 Sep; 18(9):1447-54. PubMed ID: 16442778
[TBL] [Abstract][Full Text] [Related]
13. Lipid rafts are required for Kit survival and proliferation signals.
Jahn T; Leifheit E; Gooch S; Sindhu S; Weinberg K
Blood; 2007 Sep; 110(6):1739-47. PubMed ID: 17554062
[TBL] [Abstract][Full Text] [Related]
14. Baseline and stimulated turnover of cell surface c-Kit expression in different types of human mast cells.
Babina M; Rex C; Guhl S; Thienemann F; Artuc M; Henz BM; Zuberbier T
Exp Dermatol; 2006 Jul; 15(7):530-7. PubMed ID: 16761962
[TBL] [Abstract][Full Text] [Related]
15. Dimerization of Kit-ligand and efficient cell-surface presentation requires a conserved Ser-Gly-Gly-Tyr motif in its transmembrane domain.
Paulhe F; Wehrle-Haller M; Jacquier MC; Imhof BA; Tabone-Eglinger S; Wehrle-Haller B
FASEB J; 2009 Sep; 23(9):3037-48. PubMed ID: 19386768
[TBL] [Abstract][Full Text] [Related]
16. A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses.
Smrž D; Bandara G; Zhang S; Mock BA; Beaven MA; Metcalfe DD; Gilfillan AM
J Immunol Methods; 2013 Apr; 390(1-2):52-62. PubMed ID: 23357051
[TBL] [Abstract][Full Text] [Related]
17. PI3-kinase p110α mediates β1 integrin-induced Akt activation and membrane protrusion during cell attachment and initial spreading.
Zeller KS; Idevall-Hagren O; Stefansson A; Velling T; Jackson SP; Downward J; Tengholm A; Johansson S
Cell Signal; 2010 Dec; 22(12):1838-48. PubMed ID: 20667469
[TBL] [Abstract][Full Text] [Related]
18. Stem cell factor and its receptor c-Kit as targets for inflammatory diseases.
Reber L; Da Silva CA; Frossard N
Eur J Pharmacol; 2006 Mar; 533(1-3):327-40. PubMed ID: 16483568
[TBL] [Abstract][Full Text] [Related]
19. Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.
Roskoski R
Biochem Biophys Res Commun; 2005 Dec; 338(3):1307-15. PubMed ID: 16226710
[TBL] [Abstract][Full Text] [Related]
20. The tyrosine kinase CSK associates with FLT3 and c-Kit receptors and regulates downstream signaling.
Kazi JU; Vaapil M; Agarwal S; Bracco E; Påhlman S; Rönnstrand L
Cell Signal; 2013 Sep; 25(9):1852-60. PubMed ID: 23707526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
